Answers are grounded in this paper and cite their sources.
Enzyme-linked immunospot assays (ELISPOT) were initially developed to detect and quantify individual antibody-secreting B cells. As the sensitivity of this assay improved, the much smaller amounts of cytokine and chemokine produced by individual T cells became amenable to detection. ELISPOT assays utilize high-affinity antibody pairs directed against different epitopes on a single cytokine/chemokine. The critical first step involves binding the highest affinity Ab to a solid matrix. The plates are blocked to prevent nonspecific interactions, and the cells of interest incubated in the Ab-coated wells, during which time they secrete the cytokine/chemokine of interest. The secreted protein binds to the Abs immediately below the producer cell. This bound protein is recognized by a secondary enzyme-linked Ab. A colorimetric substrate is used to generate a dark precipitate or "spot" that marks the position of the protein-producing cell. The resultant spots are permanent and can be quantified visually, microscopically, or electronically.
No takes yet. Share an insight, caveat, or question.
Dennis M. Klinman (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: